Home > Healthcare > Medical Devices > Diagnostic Devices > Liquid Biopsy Market
Liquid Biopsy Market Share
- Report ID: GMI3775
- Published Date: Nov 2021
- Report Format: PDF
Liquid Biopsy Market Share
Major companies operating in the liquid biopsy market are:
- F. Hoffmann-La Roche Ltd
- BIOCEPT Inc
- QIAGEN
- Myriad Genetics, Inc
- Guardant Health, Inc
- Illumina, Inc
- Lucence health Inc
- EPIGENOMICS AG.
These participants are adopting various growth strategies such as collaborations, acquisitions & mergers, partnerships, and product launches to gain competitive edge over others.
Frequently Asked Questions (FAQ) :
Market size of liquid biopsy surpassed USD 1.2 billion in 2020 and is expected to expand at a CAGR of 29.7% from 2021 to 2027 with increasing awareness regarding the causes and diagnosis of cancer.
The kits & reagents accounted for over 50% of the revenue share in 2020 and will grow with soaring adoption of liquid biopsy in research institutes and reference laboratories.
The lung cancer is poised to exhibit a growth rate of 29.7% up to 2027 owing to the growing adoption of unhealthy lifestyle, comprising tobacco consumption and smoking, and a subsequent increase in the incidence rate.
North America market size recorded 31% of the global industry revenue in 2020 and will rise with the availability of highly advanced infrastructure and faster adoption of advanced methods.
Major players across the industry comprise Guardant Health, Inc., F. Hoffmann-La Roche Ltd., Lucence Health Inc., Genetics, Inc., BIOCEPT, Inc., and others.
Liquid Biopsy Market Scope
×
Get a free sample of
Liquid Biopsy Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below